FMC's (FMC) Q1 results were weighed down by pricing headwinds from cost pass-through and generic competition, which are likely to persist through the rest of H1, RBC Capital Markets said in a note emailed Friday.
The firm said that FMC expects new product launches and growth in the plant health segment to drive year-over-year improvement in H2, but the company would need a solid H2 beat to boost investor confidence.
Price and foreign exchange pressures remained a headwind in April, slightly offset by better volume and costs, RBC said.
FMC expects destocking to be largely resolved by the end of Q2 in all regions except Asia, according to the note.
The firm maintained its sector perform rating on FMC's stock with a $40 price target.
Shares of FMC were down 1.5% in recent trading.
Price: 37.89, Change: -0.56, Percent Change: -1.46
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。